1. Home
  2. MTEM vs NURO Comparison

MTEM vs NURO Comparison

Compare MTEM & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTEM
  • NURO
  • Stock Information
  • Founded
  • MTEM N/A
  • NURO 1996
  • Country
  • MTEM United States
  • NURO United States
  • Employees
  • MTEM N/A
  • NURO N/A
  • Industry
  • MTEM Biotechnology: Biological Products (No Diagnostic Substances)
  • NURO Medical/Dental Instruments
  • Sector
  • MTEM Health Care
  • NURO Health Care
  • Exchange
  • MTEM Nasdaq
  • NURO Nasdaq
  • Market Cap
  • MTEM 8.5M
  • NURO 7.7M
  • IPO Year
  • MTEM N/A
  • NURO N/A
  • Fundamental
  • Price
  • MTEM $1.34
  • NURO $3.80
  • Analyst Decision
  • MTEM
  • NURO
  • Analyst Count
  • MTEM 0
  • NURO 0
  • Target Price
  • MTEM N/A
  • NURO N/A
  • AVG Volume (30 Days)
  • MTEM 23.9K
  • NURO 8.2K
  • Earning Date
  • MTEM 08-08-2024
  • NURO 07-29-2024
  • Dividend Yield
  • MTEM N/A
  • NURO N/A
  • EPS Growth
  • MTEM N/A
  • NURO N/A
  • EPS
  • MTEM N/A
  • NURO N/A
  • Revenue
  • MTEM $31,763,000.00
  • NURO $5,270,210.00
  • Revenue This Year
  • MTEM N/A
  • NURO N/A
  • Revenue Next Year
  • MTEM N/A
  • NURO N/A
  • P/E Ratio
  • MTEM N/A
  • NURO N/A
  • Revenue Growth
  • MTEM N/A
  • NURO N/A
  • 52 Week Low
  • MTEM $1.01
  • NURO $2.70
  • 52 Week High
  • MTEM $9.45
  • NURO $7.92
  • Technical
  • Relative Strength Index (RSI)
  • MTEM 52.66
  • NURO 53.56
  • Support Level
  • MTEM $1.21
  • NURO $3.65
  • Resistance Level
  • MTEM $1.50
  • NURO $4.10
  • Average True Range (ATR)
  • MTEM 0.11
  • NURO 0.15
  • MACD
  • MTEM 0.02
  • NURO 0.02
  • Stochastic Oscillator
  • MTEM 56.76
  • NURO 49.50

About MTEM Molecular Templates Inc.

Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

Share on Social Networks: